IDiyas

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Alba Therapeutics Corporation


USPTO Granted Patents = 16



Forward Citations = 126

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Blake Paterson (9 out of 14 patents)

silverMedal Amir P Tamiz (8 out of 12 patents)

bronzeMedal Sefik Alkan (3 out of 3 patents)

4.  Kelly Marie Kitchens (3 out of 3 patents)

5.  Malarvizhi Durai (3 out of 3 patents)

6.  Neil Poloso (3 out of 3 patents)

7.  Rosa A Carrasco (3 out of 3 patents)

8.  Alessio Fasano (3 out of 30 patents)

9.  Mark J Ginski (3 out of 3 patents)

10.  Niranjan B Pandey (2 out of 14 patents)

11.  Thierry Delplanche (1 out of 9 patents)

12.  Peter Ward (1 out of 1 patent)

13.  Roland Callens (1 out of 25 patents)

14.  Georges Blondeel (1 out of 8 patents)

15.  Dorothea Sesardic (1 out of 1 patent)


16 patents:

1. 11149063 - Peptide inhibitors of tight junction permeability (2021-10-19),
2. 10723763 - Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome (2020-07-28),
3. 10526372 - Inhibition of gliadin peptides (2020-01-07),
4. 9279807 - Materials and methods for the treatment of celiac disease (2016-03-08),
5. 9265811 - Formulations for a tight junction effector (2016-02-23),
6. 9241969 - Method for treating celiac disease (2016-01-26),
7. 9051349 - Larazotide acetate compositions (2015-06-09),
8. 8957032 - Inhibition of gliadin peptides (2015-02-17),
9. 8796203 - Use of tight junction antagonists to treat inflammatory bowel disease (2014-08-05),
10. 8785374 - Inhibitors of mammalian tight junction opening (2014-07-22),
11. 8728491 - Transcutaneous delivery of therapeutic agents (2014-05-20),
12. 8557763 - Synthetic peptides that enhance tight junction permeability (2013-10-15),
13. 8299017 - Use of tight junction antagonists to treat inflammatory bowl disease (2012-10-30),
14. 8198233 - Synthetic peptides that enhance tight junction permeability (2012-06-12),
15. 8168594 - Method for treating celiac disease (2012-05-01),
ALBA THERAPEUTICS CORPORATION is a biotechnology company that develops novel treatments for autoimmune and inflammatory diseases. With a focus on celiac disease and other gastrointestinal disorders, Alba Therapeutics is dedicated to improving the lives of patients through innovative research and development. They have a pipeline of potential therapeutics that target the underlying immune response and aim to provide effective and safe treatments for these debilitating conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#30 in Baltimore, MD

#265 in Maryland

#19,271 in US

#36,634 in the World

...
Baltimore, MD, United States of America

Alba Therapeutics Corporation

Forward Citations = 126

17 inventors:

goldMedal Blake Paterson (9 out of 14 patents)

silverMedal Amir P Tamiz (8 out of 12 patents)

bronzeMedal Sefik Alkan (3 out of 3 patents)

4.  Kelly Marie Kitchens (3 out of 3 patents)

5.  Malarvizhi Durai (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…